References
- Eble J N, Sauter G, Epstein J I, et al. World Health Organization Classification of Tumors: Tumors of the Urinary System and Male Genital Organs. IARC Press, Lyon 2004; 9–88
- Argani P, Antonescu C R, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 2002; 26: 1553–1566
- Argani P, Antonescu C R, Illei P B, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179–192
- Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750–761
- Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med 2005; 25: 363–378
- Granter S R, Perez-Atayde A R, Andrew A, et al. Cytologic analysis of papillary renal cell carcinoma. Cancer Cytopathol 1998; 84: 303–308
- Meyer P N, Clark J I, Flanigan R C, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adult patients. Int Braz J Urol 2006; 33: 365–366
- Salles P GO, Soto M, Jr. Kidney carcinoma associated with Xp11.2 translocation/TFE3 (ASPL-TFE3) gene fusion. Int Braz J Urol 2005; 31: 251–255
- Mansouri D, Dimet S, Couanet D, et al. Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features. Diagn Cytopathol 2006; 34: 757–760
- Schinstine M, Filie A C, Torres-Cabala C, et al. Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature. Diagn Cytopathol 2006; 34: 751–756